Repomine M 1mg/500mg Tablet
Product Info
Prescription required | Yes |
Marketer | Shinto Organics (P) Limited |
Active Ingredient | Repaglinide (1mg) + Metformin (500mg) |
Storage | Store below 30°C |
Habit Forming | No |
Therapeutic Class | ANTI DIABETIC |
User Rating | 4.7 |
User Reviews | 564 |
FAQ
Repomine M 1mg/500mg Tablet Reviews
Repomine M 1mg/500mg should be taken with food. Take it regularly at the same time each day to get the most benefit. Your doctor will decide what dose is best for you and this may change from time to time according to how it is working according to your blood sugar levels.
Keep taking this medicine, even if you feel well or your blood sugar levels are controlled. If you stop it without consulting your doctor, your blood sugar levels could rise and put you at risk of kidney damage, blindness, nerve problems and loss of limbs. Remember that it is only part of a treatment program that should also include a healthy diet, regular exercise, and weight reduction as advised by your doctor. Your lifestyle plays a big part in controlling diabetes.
The most common side effect of Repomine M 1mg/500mg is low blood glucose levels (hypoglycemia). Make sure you recognize the signs of having low blood glucose levels, such as sweating, dizziness, headache, and shaking and know how to deal with it. To prevent this, it's important to have regular meals and always carry a fast-acting source of glucose such as sugary food or fruit juice with you. Drinking alcohol can also increase your risk of low blood sugar levels and should be avoided. Other side effects that may be seen in taking this medicine include taste changes, nausea, diarrhea, stomach pain, headache, and upper respiratory tract infection. Some people may find that they put on weight with this medicine.
You should not take it if you have type 1 diabetes mellitus, if you have diabetic ketoacidosis (high levels of acid in your blood), or if you have severe kidney or liver disease. Before taking this medicine, tell your doctor if you have ever had heart disease. It may not be suitable. Pregnant or breastfeeding women should also consult their doctor before taking it. Your blood sugar levels should be checked regularly and your doctor may also advise blood tests to monitor your blood cell counts and liver function.
How Repomine M 1mg/500mg Tablet Works
How to Use Repomine M 1mg/500mg Tablet
Uses of Repomine M 1mg/500mg Tablet
- Type 2 diabetes mellitus
Repomine M 1mg/500mg Tablet Side Effects
Safety Tips
Quick Tips
- Monitor your blood sugar regularly while taking this medicine.
- It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
- You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines (if prescribed) along with Repomine M 1mg/500mg.
- You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines (if prescribed) along with Repomine M 1mg/500mg.
- It is fast-acting and reaches full effect within an hour.
- It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
- Always carry some sugary food or fruit juice with you in case you experience hypoglycemia symptoms such as cold sweats, cool pale skin, tremor, and anxious feeling.
- Always carry some sugary food or fruit juice with you in case you experience hypoglycemia symptoms such as cold sweats, cool pale skin, tremor, and anxious feeling.
- It is fast-acting and reaches full effect within an hour.
- Monitor your blood sugar regularly while taking this medicine.
References
- Repaglinide and metformin hydrochloride [FDA Prescribing Information]. Bagsvaerd, Denmark: Novo Nordisk A/S; 2012.
- DailyMed. Repaglinide and metformin hydrochloride.
- Repaglinide and metformin HCl. Princeton, New Jersey: Novo Nordisk Inc; 2008 [revised Mar. 2012].
- Medscape. Repaglinide+Metformin.
- Repaglinide and Metformin Hydrochloride Tablets [Patient Information Sheet]. Ahmedabad, Gujarat: Torrent Pharmaceuticals Ltd.; 2016.